Biochemists created a polymer film derived from soy proteins in a sustainable process that can replace many of today’s single-use plastics. . . . → Read More: Plant-Based Material Designed to Replace Plastics
|
|||||
|
       
  |
Two U.S. government health agencies agreed to purchase some 1.7 million doses of a Covid-19 antiviral drug, once the drug receives clearance from FDA. . . . → Read More: U.S. to Buy Covid-19 Antiviral Drug in $1.2B Deal 
A new company is underway commercializing research on gene therapies for inherited diseases, staked to an initial investment of $200 million. . . . → Read More: Gene Therapy Company Starts-Up, Gains $200M  Comments are closed  Intellectual property, New products  Asia, biomedical, biotechnology, entrepreneurs, equity, genomics, investment, licensing, life sciences, pharmaceuticals, university, venture capital 
Two biotechnology companies are collaborating on using the gene editing technique Crispr to create engineered immune-system cells to treat cancer. . . . → Read More: Biotechs Partner on Gene-Edited Cancer Cell Therapies 2 comments - (Comments are closed) Intellectual property, Joint ventures/collaborations biomedical, biotechnology, cancer, Europe, genomics, licensing, life sciences, pharmaceuticals 
A company using machine learning to create engineered viruses to deliver gene therapies is raising $100 million in its first venture funding round. . . . → Read More: AI Gene Therapy Platform Gains $100M in Early Funds One comment - (Comments are closed) Finance, New products biomedical, biotechnology, engineering, equity, genomics, investment, licensing, life sciences, mathematics, pharmaceuticals, physical sciences, university, venture capital 
Spark Therapeutics, a developer of gene therapies, is gaining access to a technology that programs DNA sequences like integrated electronic circuits. . . . → Read More: Gene Therapy Company Exploring DNA Circuit Technology Comments are closed Intellectual property, Joint ventures/collaborations biomedical, biotechnology, engineering, entrepreneurs, genomics, licensing, life sciences, pharmaceuticals, university 
A clinical trial shows a drug designed to reduce inflammation in autoimmune disease patients does not clearly help patients hospitalized with Covid-19 disease. . . . → Read More: Arthritis Drug Unsuccessful for Covid-19 Hospital Patients Comments are closed Joint ventures/collaborations biomedical, clinical trials, Covid-19, licensing, life sciences, NIH, pharmaceuticals 
A biotechnology company designing vaccines for viral diseases including Covid-19 is raising $100 million in its second venture funding round. . . . → Read More: Infectious Disease Biotech Raises $100M in Venture Funds One comment - (Comments are closed) Finance biomedical, biotechnology, clinical trials, Covid-19, equity, investment, licensing, life sciences, mathematics, nanotechnology, NIH, pharmaceuticals, physical sciences, preclinical, university, venture capital 
A medical device company now offers a synthetic tissue implant for torn rotator cuff, a common sports injury, designed at a Purdue University engineering lab. . . . → Read More: Univ. Lab Develops, Licenses Sports Injury Implant Comments are closed Intellectual property, New products biomedical, biotechnology, engineering, licensing, life sciences, medical device, university 
A developer of vaccines, including a leading Covid-19 vaccine, and cancer immunotherapies, is raising $168 million in its second venture round. . . . → Read More: Vaccine Spin-Off Raises $168 Million in New Funds Comments are closed Finance biomedical, biotechnology, cancer, clinical trials, Covid-19, equity, investment, licensing, life sciences, pharmaceuticals, U.K., university, venture capital |
||||
|
Copyright © 2021 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||